AF
Andrew Fein HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
183
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
88.5%
Neutral
11.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Reiterated
| $12 |
27%
upside
| 2 | +9.7% |
0
%
| 20 Oct ‘25 yesterday |
|
|
Neutral
Downgraded
| $54 |
0%
downside
| 2 | +19% |
0
%
| 10 Oct ‘25 11 days ago |
|
|
Buy
Maintained
| $20 |
94%
upside
| 2 | -2.5% |
0
%
| 7 Oct ‘25 14 days ago |
|
|
Buy
Reiterated
| $35 |
43%
upside
| 1 | +21% |
0
%
| 6 Oct ‘25 15 days ago |
|
|
Buy
Maintained
| $95 |
27%
upside
| 2 | +31% |
0
%
| 25 Sep ‘25 26 days ago |
|
|
Neutral
Downgraded
| $14.50 |
2%
downside
| 2 | +62% |
0
%
| 19 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $70 |
18%
upside
| 1 | +27% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $500 |
18%
upside
| 2 | +4.7% |
0
%
| 5 Sep ‘25 1 month ago |
|
|
Neutral
Assumed
| $7.44 |
9%
downside
| 1 | – |
–
| 4 Sep ‘25 1 month ago |
|
|
Buy
Assumed
| $500 |
14%
upside
| 1 | +0.38% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
Buy
Assumed
| $60 |
172%
upside
| 1 | +26% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
Buy
Reiterated
| $22 |
187%
upside
| 1 | -11% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $8 |
100%
upside
| 2 | -4.7% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $240 |
46%
upside
| 1 | +18% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $18 |
84%
upside
| 1 | -8.8% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $25 |
232%
upside
| 1 | +9% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $478 |
13%
upside
| 1 | -1.7% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $194 |
33%
upside
| 1 | -3.2% |
0
%
| 1 Aug ‘25 2 months ago |
|